Product
DA
1 clinical trial
1 indication
Indication
chronic kidney diseaseClinical trial
A Phase 3 Multi-center, Randomized, Open-label, Active-comparator (Darbepoetin Alfa) Conversion Study of Intermittent Oral Dosing of ASP1517 in Non-dialysis Chronic Kidney Disease Patients With AnemiaStatus: Completed, Estimated PCD: 2019-09-13